Knut Reidar Wangen
Papers
1
Total Citations
2
H-Index
1
About
Knut Reidar Wangen is a health economist whose research bridges clinical decision-making and economic evaluation, with a focus on cancer care. His work centers on cost-effectiveness analysis, particularly in gynecologic oncology, where he evaluates the trade-offs between surgical innovation and healthcare resource allocation. Wangen’s most cited study, a 2024 cost-effectiveness analysis of sentinel lymph node biopsy versus lymphadenectomy in intermediate- and high-risk endometrial carcinoma, demonstrates his ability to translate complex clinical trade-offs into actionable economic insights. This work, already garnering early citations, models the impact of adopting less invasive staging algorithms, weighing survival benefits, complication rates, and healthcare costs. By quantifying the value of sentinel node mapping, Wangen provides evidence that can shape surgical guidelines and reimbursement policies. His research is notable for its methodological rigor and practical relevance, helping clinicians and policymakers navigate the adoption of emerging technologies. With a growing citation footprint, Wangen is establishing himself as a key voice in the economic evaluation of cancer surgery, contributing to a more sustainable and evidence-based healthcare system.
Research Focus
Key Achievements
Top Papers
- 1